Finch Therapeutics Group
Manufacturing · Massachusetts, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
200 Innerbelt Rd Ste 400, Somerville, Ma...Phone Number
(617) 229-6499Website
www.finchtherapeutics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Finch Therapeutics Group
Finch Therapeutics Group is a clinical-stage bio-pharmaceutical company focused on developing and delivering innovative therapies that harness the human gut microbiome. The company was established in 2017 and is headquartered out of Somerville, MA.Explore more
Finch Therapeutics Group Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Finch Therapeutics Group your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Finch Therapeutics Group, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Finch Therapeutics Group
Earning: See what the market has to say on Finch Therapeutics Group recently announced quarterly report
Check if Finch Therapeutics Group has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Finch Therapeutics Group has new funding data
Check out if Finch Therapeutics Group is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Click to see if Finch Therapeutics Group had a recent Job posting/layoffs
Product Launch: Get notified when Finch Therapeutics Group launches new products
Recommended Actions
Reach out to Masked Content who joined Finch Therapeutics Group as Masked Content
Find more new buyers
Compare Similar Companies to Finch Therapeutics Group
Compare insights from companies similar to Finch Therapeutics Group, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Finch Therapeutics Group is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Finch Therapeutics Group is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Finch Therapeutics Group.
Finch Therapeutics Group financials insights
Gather financial insights about Finch Therapeutics Group, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2017
Series A
$5.6M
2018
Series B
$36M
2019
Series C
$53M
2020
Debt
$1M
Series D
$90M
2021
Stock Offering
$128M
Finch Therapeutics Group Tech Stack
A closer look at the technologies used by Finch Therapeutics Group
See more technologies
Most Recent Scoops
Earnings
Asset Management, Intellectual Property
Earnings
Employee Relations, Employee Retention, Legal Affairs
Earnings
Asset Management, Database, Financial Planning, Intellectual Property
Earnings
Asset Management
Earnings
Asset Management, Business Intelligence, Financial Planning, Business Development
Finch Therapeutics Group News & Media
Finch Announces Reverse Stock Split of Common Stock
BOSTON, June 09, 2023 (GLOBE NEWSWIRE) -- Finch Therapeutics Group, Inc. (“Finch”, “Finch Therapeutics” or the “Company”) (Nasdaq: FNCH), a microbiome technology company with a portfolio of intellectual property and microbiome assets, today announced it will effect a one-for-30 reverse stock split of its issued and outstanding common stock. Finch stockholders approved an amendment to its Amended and Restated Certificate of Incorporation to effect the reverse stock split at Finch’s Annual MeetingFinch Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Updates
SOMERVILLE, Mass., May 10, 2023 (GLOBE NEWSWIRE) -- Finch Therapeutics Group, Inc. (“Finch”, “Finch Therapeutics” or the “Company”) (Nasdaq: FNCH), a microbiome technology company with a portfolio of intellectual property and microbiome assets, today reported first quarter 2023 financial results and provided business updates.Finch Therapeutics Announces Executive Leadership Transitions
Matthew P. Blischak, an experienced life sciences executive and intellectual property counsel, appointed as Chief Executive Officer effective May 16, 2023; Mark Smith, PhD, to complete his time as CEO effective May 15Finch Therapeutics Announces Clinical Collaboration in Ulcerative Colitis with Brigham and Women’s Hospital and Updates to University of Minnesota License Agreement
SOMERVILLE, Mass., April 18, 2023 (GLOBE NEWSWIRE) -- Finch Therapeutics Group, Inc. (“Finch”, “Finch Therapeutics” or the “Company”) (Nasdaq: FNCH), a microbiome technology company with a portfolio of intellectual property and microbiome assets, today announced that it has entered into a clinical trial agreement with Brigham and Women’s Hospital for the evaluation of CP101, a Complete Consortia microbiome therapeutic, in ulcerative colitis. The Company also announced updates to its license agre
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Finch Therapeutics Group
Sign Up For FreeTo access detailed company insights
Finch Therapeutics Group is a clinical-stage bio-pharmaceutical company focused on developing and delivering innovative therapies that harness the human gut microbiome. The company was established in 2017 and is headquartered out of Somerville, MA.... Read More
